| Conţinutul numărului revistei |
| Articolul precedent |
| Articolul urmator |
 |
 374 0 |
| Căutarea după subiecte similare conform CZU |
| 616.98:578.834.1:614.1(612) (1) |
| Boli transmisibile. Boli infecţionase şi contagioase, stări febrile (586) |
| Virologie (446) |
| Populare. Depopulare (22) |
 SM ISO690:2012AQEEHAL, Hanan, ALARBI, Ahmed, MANEEA, Haytham, BENMANSUR, Mahmud, ELTURKI, Abdelhadi, ZAABIA, Anud, BENTOUTA, Rachid, GEBRIL, Jebril. Retrospective study on the prevalence of COVID-19 confirmed cases and evidence of gender bias in Libya. In: One Health and Risk Management, 2022, nr. 3(1), pp. 29-37. ISSN 2587-3458. DOI: https://doi.org/10.38045/ohrm.2022.1.01 |
| EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
| One Health and Risk Management | ||||||
| Numărul 3(1) / 2022 / ISSN 2587-3458 /ISSNe 2587-3466 | ||||||
|
||||||
| DOI:https://doi.org/10.38045/ohrm.2022.1.01 | ||||||
| CZU: 616.98:578.834.1:614.1(612) | ||||||
| Pag. 29-37 | ||||||
|
||||||
 Descarcă PDF |
||||||
| Rezumat | ||||||
Introduction. To stop SARS-CoV-2 from spreading, it's crucial to have a solid understanding of the baseline characteristics of demographic variables, clinical symptoms, and comorbidity so that quarantining and testing protocols can be developed. Material and methods. A ret-rospective study was conducted on COVID-19 Laboratory confirmed cases. Data were col-lected by using kobo toolbox, demographic variables, clinical symptoms, and Comorbidity was considered. Yates-corrected chi2 tests and Multinomial Logistic Regression was used to esti-mate the odds ratio (OR) and 95% confidence interval (CI) of factors and their impact on COVID-19 prevalence. Results. A total of 6302 of which 3536(56.1%) men and 2766 (44%) women with a mean age (±SD) of 44±17.6 years were included within the study. Clinical symp-toms and Comorbidity were significant for both sexes p<0.0001. Multinomial Logistic Regres-sion confirmed that age <55, 3 or more symptoms (OR=1.130 CI95% 1.013-1.261) and 3 or more comorbidities (OR=1.035 Cl95% 0.942-1.137) were a significant risk factor for COVID-19 prevalence in male patients, among women, age 85>/=, 3 or more symptoms (p<0.0001, OR=1.995 CI95% 1.335-2.992) and 3 or more comorbidities (p<0.0001, OR=1.538 Cl95% 1.045-2.640) were significant risk factor for COVID-19 prevalence in females. Conclusions. Our study suggests that the prevalence of COVID-19 patients and symptoms was higher in men than women. The high prevalence of smoking could have contributed to the high prevalence of COVID-19 among men. Study also suggests that the presence of at least one or combined comorbidities are risk factors of COVID-19 prevalence and a potential risk factor COVID-19 - related outcomes. More efforts should be exercised to protect patients with one or more comorbidities from being exposed to infection. |
||||||
| Cuvinte-cheie SARS-CoV-2, comorbidity, clinical symptoms, Libya, SARS-CoV-2, comor-biditate, simptome clinice, Libia |
||||||
|
Dublin Core Export
<?xml version='1.0' encoding='utf-8'?> <oai_dc:dc xmlns:dc='http://purl.org/dc/elements/1.1/' xmlns:oai_dc='http://www.openarchives.org/OAI/2.0/oai_dc/' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xsi:schemaLocation='http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd'> <dc:creator>Aqeehal, H.</dc:creator> <dc:creator>Alarbi, A.</dc:creator> <dc:creator>Maneea, H.</dc:creator> <dc:creator>Benmansur, M.</dc:creator> <dc:creator>Elturki, A.</dc:creator> <dc:creator>Zaabia, A.</dc:creator> <dc:creator>Bentouta, R.</dc:creator> <dc:creator>Gebril, J.</dc:creator> <dc:date>2022-01-05</dc:date> <dc:description xml:lang='en'><p>Introduction. To stop SARS-CoV-2 from spreading, it's crucial to have a solid understanding of the baseline characteristics of demographic variables, clinical symptoms, and comorbidity so that quarantining and testing protocols can be developed. Material and methods. A ret-rospective study was conducted on COVID-19 Laboratory confirmed cases. Data were col-lected by using kobo toolbox, demographic variables, clinical symptoms, and Comorbidity was considered. Yates-corrected chi2 tests and Multinomial Logistic Regression was used to esti-mate the odds ratio (OR) and 95% confidence interval (CI) of factors and their impact on COVID-19 prevalence. Results. A total of 6302 of which 3536(56.1%) men and 2766 (44%) women with a mean age (±SD) of 44±17.6 years were included within the study. Clinical symp-toms and Comorbidity were significant for both sexes p<0.0001. Multinomial Logistic Regres-sion confirmed that age <55, 3 or more symptoms (OR=1.130 CI95% 1.013-1.261) and 3 or more comorbidities (OR=1.035 Cl95% 0.942-1.137) were a significant risk factor for COVID-19 prevalence in male patients, among women, age 85>/=, 3 or more symptoms (p<0.0001, OR=1.995 CI95% 1.335-2.992) and 3 or more comorbidities (p<0.0001, OR=1.538 Cl95% 1.045-2.640) were significant risk factor for COVID-19 prevalence in females. Conclusions. Our study suggests that the prevalence of COVID-19 patients and symptoms was higher in men than women. The high prevalence of smoking could have contributed to the high prevalence of COVID-19 among men. Study also suggests that the presence of at least one or combined comorbidities are risk factors of COVID-19 prevalence and a potential risk factor COVID-19 - related outcomes. More efforts should be exercised to protect patients with one or more comorbidities from being exposed to infection.</p></dc:description> <dc:description xml:lang='ro'><p>Introducere. Pentru a stopa răspândirea SARS-CoV-2, este esențial să fie bine înțelese carac-teristicile de bază ale variabilelor demografice, simptomele clinice și comorbiditatea, astfel încât să poată fi dezvoltate protocoale de carantină și de testare. Material și metode. A fost efectuat un studiu retrospectiv pe cazurile confirmate de laboratorul COVID-19. S-au colectat date prin aplicarea Kobo toolbox, luându-se în considerare variabilele demografice, simp-tomele clinice și comorbiditatea. Pentru a estima riscul relativ (OR), intervalul de încredere de 95% (CI) al factorilor și impactul acestora asupra prevalenței COVID-19, au fost utilizate Yates corecția pentru testele chi pătrat și regresia logistică multinominală. Rezultate. În stu-diu au fost incluse 6302 persoane, dintre care 3536 (56,1%) bărbați și 2766 (44%) femei, cu vârsta medie (±SD) de 44±17,6 ani. Simptomele clinice și comorbiditatea au fost semnificative pentru ambele sexe p<0,0001. Regresia logistică multinominală a confirmat că vârsta <55, 3, mai multe simptome (OR=1,130 CI95% 1,013-1,261), 3 sau mai multe comorbidități (OR=1,035 CL95% 0,942-1,137) au constituit un factor de risc semnificativ pentru prevalența COVID-19 la bărbați, iar în rândul femeilor, vârsta de 85 de ani >/=, 3 sau mai multe simptome (p<0,0001, OR=1,995 CI95% 1,35-2,992), 3 sau mai multe comorbidități (p<0,0001 OR=1,538 CL95% 1,045-2,640) au prezentat factori de risc semnificativ pentru incidența COVID-19. Concluzii. Studiul constată că prevalența pacienților și a simptomelor COVID-19 a fost mai mare la bărbați decât la femei. Nivelul ridicat al fumatului ar fi putut contribui la incidența înaltă de COVID-19 în rândul bărbaților. Cercetarea noastră sugerează, de asemenea, că prezența a cel puțin uneia dintre comorbidități sau a unor comorbidităților combinate sporește riscul incidenței COVID-19 și se prezintă ca un potențial factor de risc COVID-19 – rezultatele fiind asociate. Ar trebui să se depună mai multe eforturi în scopul protejării pa-cienților cu una sau cu mai multe comorbidități de expunerea la infecții.</p></dc:description> <dc:identifier>10.38045/ohrm.2022.1.01</dc:identifier> <dc:source>One Health and Risk Management 1 (3) 29-37</dc:source> <dc:subject>SARS-CoV-2</dc:subject> <dc:subject>comorbidity</dc:subject> <dc:subject>clinical symptoms</dc:subject> <dc:subject>Libya</dc:subject> <dc:subject>SARS-CoV-2</dc:subject> <dc:subject>comor-biditate</dc:subject> <dc:subject>simptome clinice</dc:subject> <dc:subject>Libia</dc:subject> <dc:title>Retrospective study on the prevalence of COVID-19 confirmed cases and evidence of gender bias in Libya</dc:title> <dc:type>info:eu-repo/semantics/article</dc:type> </oai_dc:dc>
|
|
|
